SGRY - NASDAQ
Surgery Partners, Inc.
$13.51
+2.2%Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
At a Glance
Live SnapshotSurgery Partners, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Effective Tax Rate
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Profitability Insight
Non-operating losses: Core business is profitable but other expenses (interest, taxes, one-time items) are driving net losses. Review capital structure and non-operating items.
Surgery Partners, Inc. Income Statement
SGRY • NASDAQ
| Surgery Partners, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||
3.3B | 3.1B | 2.7B | 2.5B | 2.2B | 1.9B | 1.8B | 1.8B | 1.3B | 1.1B | 959.9M | 403.3M | 284.6M | 260.2M | |
GROSS PROFIT | ||||||||||||||
(2.5B) | (2.4B) | (2.1B) | (2B) | (1.7B) | (1.5B) | (1.4B) | (1.4B) | (1B) | (821.2M) | (669.3M) | (254.2M) | (169.8M) | (159.3M) | |
765M | 745.6M | 647.5M | 574.9M | 491.4M | 379.8M | 423.8M | 410M | 327.4M | 324.2M | 290.6M | 149.1M | 114.8M | 100.9M | |
OPERATING INCOME | ||||||||||||||
(375.5M) | (396.8M) | (319.5M) | (229.7M) | (189.2M) | (196.8M) | (187.9M) | (157.2M) | (156.4M) | (123.7M) | (111.8M) | (52.7M) | (44.2M) | (39.6M) | |
(522.7M) | (138.7M) | (120.9M) | (102.2M) | (104M) | (97.1M) | (88.6M) | (93.6M) | (76M) | (60.2M) | (56M) | (31.5M) | (26.3M) | (25.3M) | |
389.5M | 348.8M | 328M | 345.2M | 302.2M | 183M | 235.9M | 77.8M | 158.2M | 196.5M | 144.8M | 50.8M | 58.2M | 60.5M | |
PRE-TAX INCOME | ||||||||||||||
(272.6M) | (201.7M) | (193M) | (234.9M) | (221M) | (201.8M) | (178.9M) | (147M) | (117.7M) | (100.6M) | (101M) | (62.1M) | (32.9M) | (28.5M) | |
-272.6M | -201.7M | -193M | -234.9M | -221M | -201.8M | -178.9M | -147M | 0.0 | -100.6M | -101M | -62.1M | -32.9M | -28.5M | |
-147.2M | (258.1M) | (198.6M) | (127.5M) | (85.2M) | (99.7M) | (99.3M) | (63.7M) | (25.3M) | -3.7M | -119.9M | (21.2M) | (17.8M) | (14.3M) | |
-272.6M | -201.7M | -193M | -234.9M | -221M | -201.8M | -181.3M | -147M | -75.9M | -104.3M | -220.9M | -62.1M | -32.9M | -29.3M | |
116.9M | 147.1M | 135M | 110.3M | 81.2M | -18.8M | 54.6M | -69.2M | 82.3M | 92.2M | -76.1M | -11.3M | 25.3M | 32M | |
NET INCOME | ||||||||||||||
(18M) | (134.6M) | -300K | (23.3M) | (10.5M) | -20.1M | (9.5M) | (26.5M) | (53.6M) | (7.1M) | -149M | (15.8M) | (7.6M) | (6.1M) | |
-77.9M | -168.1M | -11.9M | -54.6M | -70.9M | -116.1M | -74.8M | -205.7M | -53M | 9.5M | 1.4M | -65.9M | -9.1M | 1.9M |
SEC Filings
SGRY - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 05, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 02, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 16, 2025 | December 16, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 12, 2025 | December 11, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 11, 2025 | December 11, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 12, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 10, 2025 | September 30, 2025 | 2025 |
Related Guides
Continue your SGRY research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.